ÀüÁ¾¸ñÅä·Ð
Amneal Pharmaceuticals´Â 2026³â 1¿ù 29ÀϺÎÅÍ Àü±¹ ¿ÀÇÇ¿ÀÀ̵å ÇÕÀǾÈÀ» ½ÃÇàÇÑ´Ù.
Çö±Ý 8,850¸¸ ´Þ·¯¿Í ÃÖ´ë 1¾ï 7,740¸¸ ´Þ·¯ »ó´çÀÇ ³ª·Ï¼ÕÀ» Á¦°øÇϸç, Çö±Ý Áö±Þ¾×Àº ÃÖ´ë 1¾ï 3,290¸¸ ´Þ·¯·Î Áõ°¡ÇÒ ¼ö ÀÖ´Ù.
À̷νá ȸ»ç´Â ¿ÀÇÇ¿ÀÀÌµå °ü·Ã 乫 ´ëºÎºÐÀ» ÇؼÒÇÒ Àü¸ÁÀÌ´Ù.
¾Æ¹Ì³¯, Àü±¹ ¿ÀÇÇ¿ÀÀÌµå ¼Ò¼Û ÇÕÀÇ ÀÌÇà °èȹ È®Á¤ ¾Æ¹Ì³¯Àº 2026³â 1¿ù 29ÀÏÀÚ·Î Àü±¹ ¿ÀÇÇ¿ÀÀ̵å ÇÕÀǸ¦ ½ÃÇàÇÑ´Ù.
ÀÌ ÇÕÀÇ´Â Çö±Ý°ú ³¯·Ï¼Õ °ø±ÞÀ» °áÇÕÇϸç, Çö±Ý ÃѾ×Àº ÃÖ´ë 1¾ï 3,290¸¸ ´Þ·¯¿¡ À̸¦ ¼ö ÀÖ´Ù.
ÃÖ°íÀÇ ¸Å¼ö Á¾¸ñÀ» ã°í °è½Å°¡¿ä?
(AMRX) )°¡ °ø½Ã¸¦ ¹ßÇ¥Çß´Ù.
2026³â 1¿ù 23ÀÏ, Amneal Pharmaceuticals´Â ÇØ´ç ȸ»ç¸¦ »ó´ë·Î ¼Ò¼ÛÀ» Á¦±âÇÑ ¸ðµç Àû°Ý ÁÖ ¹× ¿µÅä °ËÂûÃÑÀå°ú ¸ðµç ÇÏÀ§ Á¤ºÎ ±â°üÀ¸·ÎºÎÅÍ ÃæºÐÇÑ Âü¿© È®º¸ ÈÄ 2026³â 1¿ù 29ÀÏ¿¡ ½ÃÇàµÇ´Â Àü±¹ ¿ÀÇÇ¿ÀÀ̵å ÇÕÀǸ¦ ÀÌÇàÇÒ °ÍÀ̶ó°í ¹àÇû´Ù.
ÀÌ ÇÕÀÇ¿¡ µû¶ó ¾Æ¹Ì³¯Àº Âü¿© ÁÖÁ¤ºÎ¿Í Áö¹æ Á¤ºÎ¿¡ 8,850¸¸ ´Þ·¯¸¦ Áö±ÞÇÏ°í ¿ÀÇÇ¿ÀÀÌµå °ú´Ùº¹¿ë Ä¡·á¸¦ À§ÇÑ ³¯·Ï¼Õ ºñ° ½ºÇÁ·¹À̸¦ ÃÖ´ë 1¾ï 7,740¸¸ ´Þ·¯ »ó´ç Á¦°øÇϸç, 10³â ºÐÇÒ Áö±Þ ±â°£ÀÇ ¸¶Áö¸· 4³â µ¿¾È ÇÕÀÇ ´ç»çÀÚµéÀÌ ³¯·Ï¼Õ °¡¾×ÀÇ 25%¸¦ Çö±ÝÀ¸·Î ¼ö·ÉÇÒ ¼ö ÀÖ´Â ¿É¼ÇÀÌ ÀÖ¾î ÃÑ Çö±Ý ÁöÃâÀÌ ÃÖ´ë 1¾ï 3,290¸¸ ´Þ·¯±îÁö ´Ã¾î³¯ ¼ö ÀÖ°í À̸¦ ÅëÇØ È¸»ç´Â ¿ÀÇÇ¿ÀÀÌµå °ü·Ã 乫ÀÇ »ó´ç ºÎºÐÀ» ÇؼÒÇÒ ¼ö ÀÖ°Ô µÈ´Ù.
(AMRX) ÁֽĿ¡ ´ëÇÑ °¡Àå ÃÖ±Ù ¾Ö³Î¸®½ºÆ® µî±ÞÀº ¸Å¼ö(Buy)ÀÌ¸ç ¸ñÇ¥ÁÖ°¡´Â 15.00´Þ·¯´Ù.
Amneal Pharmaceuticals ÁֽĿ¡ ´ëÇÑ Àüü ¾Ö³Î¸®½ºÆ® Àü¸Á ¸ñ·ÏÀ» º¸·Á¸é AMRX ÁÖ½Ä Àü¸Á ÆäÀÌÁö¸¦ ÂüÁ¶Ç϶ó.
SparkÀÇ AMRX ÁÖ½Ä Æò°¡ Spark¿¡ µû¸£¸é, TipRanksÀÇ AI ¾Ö³Î¸®½ºÆ®´Â AMRX¸¦ Á߸³(Neutral)À¸·Î Æò°¡Çß´Ù.
Amneal PharmaceuticalsÀÇ ÁÖ½Ä Á¡¼ö´Â ±àÁ¤Àû ¸ð¸àÅÒÀ» ½Ã»çÇÏ´Â °·ÂÇÑ ±â¼úÀû ÁöÇ¥ÀÇ ¿µÇâÀ» ÁÖ·Î ¹Þ´Â´Ù.
±×·¯³ª ³ôÀº P/E ºñÀ²Àº °íÆò°¡ ¿ì·Á¸¦ ³º´Â´Ù.
À繫 ½ÇÀûÀº ¾ÈÁ¤ÀûÀÎ ¼ºÀåÀ» º¸ÀÌÁö¸¸ ¼öÀͼº°ú Çö±ÝÈ帧 ¼ºÀå Ãø¸é¿¡¼ °úÁ¦°¡ ÀÖ´Ù.
½ÇÀû ¹ßÇ¥ ¹× ±â¾÷ À̺¥Æ®´Â °·ÂÇÑ ¿î¿µ ½ÇÀû°ú Àü·«Àû À̴ϼÅƼºê¸¦ °Á¶ÇÏÁö¸¸ ÀÌ·¯ÇÑ ¿äÀεéÀº ÃÖÁ¾ Á¡¼ö¿¡ ¹Ý¿µµÇÁö ¾Ê´Â´Ù.
SparkÀÇ AMRX ÁÖ½Ä Àüü º¸°í¼¸¦ º¸·Á¸é ¿©±â¸¦ Ŭ¸¯Ç϶ó.
Amneal Pharmaceuticals °³¿ä Amneal Pharmaceuticals, Inc.´Â ¹Ì±¹ ±â¹Ý Á¦¾àȸ»ç·Î Á¦³×¸¯ ¹× Àü¹®ÀǾàÇ° »ê¾÷¿¡¼ ¿î¿µµÇ¸ç ´Ù¾çÇÑ Áúȯ Ä¡·áÁ¦ Æ÷Æ®Æú¸®¿À¸¦ º¸À¯ÇÏ°í ÀÖÀ¸¸ç ÅëÁõ °ü¸® ¹× Áßµ¶ Ä¡·á °ü·Ã Á¦Ç° ºÐ¾ß¿¡¼ µÎµå·¯Áø ÀÔÁö¸¦ °¡Áö°í ÀÖ´Ù.
Æò±Õ °Å·¡´ë±Ý: 1,789,198 ±â¼úÀû °¨Á¤ ½ÅÈ£: ¸Å¼ö ÇöÀç ½Ã°¡ÃѾ×: 42¾ï 7,000¸¸ ´Þ·¯ AMRX ÁÖ½ÄÀÇ Ã¶ÀúÇÑ Æò°¡¸¦ À§Çؼ´Â TipRanks ÁÖ½Ä ºÐ¼® ÆäÀÌÁö·Î À̵¿Ç϶ó.
º» ±â»ç´Â ÀΰøÁö´É(AI)À» »ç¿ëÇÏ¿© ¿µ¹®¿¡¼ Çѱ¹¾î·Î ÀÚµ¿¹ø¿ªµÇ¾ú½À´Ï´Ù. º» ±â»çÀÇ °ø½Ä ¹öÀüÀº ¿µ¹®¿øº» ÀÔ´Ï´Ù.
Amneal Finalizes Nationwide Opioid Settlement Implementation Plan
Amneal Pharmaceuticals ( (AMRX) ) has provided an announcement.
On January 23, 2026, Amneal Pharmaceuticals said it would implement a nationwide opioids settlement after securing sufficient participation from all eligible state and territorial attorneys general and all subdivisions that had sued the company, with the agreement becoming effective on January 29, 2026.
Under the settlement, Amneal will pay participating states and local governments $88.5 million and provide up to $177.4 million worth of naloxone nasal spray to treat opioid overdoses, with an option for settling parties to receive 25% of the naloxones value in cash during the final four years of the ten-year payment term, potentially raising the total cash outlay to as much as $132.9 million and helping the company resolve a substantial majority of its opioid-related liabilities.
The most recent analyst rating on (AMRX) stock is a Buy with a $15.00 price target.
To see the full list of analyst forecasts on Amneal Pharmaceuticals stock, see the AMRX Stock Forecast page.
Spark’ s Take on AMRX Stock According to Spark, TipRanks’ AI Analyst, AMRX is a Neutral.
Amneal Pharmaceuticals’ stock score is primarily influenced by its strong technical indicators, suggesting positive momentum.
However, the high P/E ratio raises concerns about overvaluation.
Financial performance shows steady growth but challenges in profitability and cash flow growth.
The earnings call and corporate events highlight strong operational performance and strategic initiatives, but these factors are not weighted in the final score.
To see Spark’ s full report on AMRX stock, click here.
More about Amneal Pharmaceuticals Amneal Pharmaceuticals, Inc.
is a U.S.-based pharmaceutical company operating in the generic and specialty drug industry, with a portfolio that includes treatments for various medical conditions and a notable presence in products related to pain management and addiction treatment.
Average Trading Volume: 1,789,198 Technical Sentiment Signal: Buy Current Market Cap: $4.27B For a thorough assessment of AMRX stock, go to TipRanks Stock Analysis page.
